NCT02868099
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
Clinical trial condition
Purpura
Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.
378 public trials
103 recruiting studies
Purpura trial results
NCT01931644
- Conditions
- ADD/ADHD, Abnormalities, Multiple, Acquired Immunodeficiency Syndrome, +282 more
- Locations
-
- Sanguine Biosciences Los Angeles, California, United States
NCT03810352
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- Boston Children's Hospital Boston, Massachusetts, United States
- Columbia University Medical Center New York, United States
- Duke University Medical Center Durham, North Carolina, United States
NCT03830749
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Humanity & Health Research Centre Hong Kong, Hong Kong SAR
NCT02077192
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Arizona Oncology Associates Tucson, Arizona, United States
- Bleeding & Clotting Disorders Institute Peoria, Illinois, United States
- Horizon Oncology Research, Inc Lafayette, Indiana, United States
- Center for Cancer and Blood Disorders Bethesda, Maryland, United States
NCT06071520
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Hospital Puerta del Mar Cadiz, Cádiz, Spain
- Hospital Universitario de Jerez de la Frontera Jerez de la Frontera, Cádiz, Spain
- Hospital de Puerto Real Puerto Real, Cádiz, Spain
- Hospital de Riotinto Minas de Ríotinto, Huelva, Spain
NCT05279872
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
- Locations
-
- Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
Completed
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
NCT03102593
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Vienna Vienna, Austria
- Wien Vienna, Austria
- Leuven Leuven, Belgium
- Mont-Godinne Namur, Belgium
NCT00117143
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
Not specified
NCT03275454
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
- Locations
-
- Georgetown Lombardi Comprehensive Cancer Center Georgetown, District of Columbia, United States
- Massachusetts General Hospital - Cancer Center Boston, Massachusetts, United States
- University of Pittsburgh Medical Center (UPMC) Hilman Cancer Center Pittsburgh, Pennsylvania, United States
- Essen University Hospital Department of Hematology Essen, Germany